(Q43266149)

17 November 2017

title

Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin (English)

1 reference

17 November 2017

T Craig Cheetham

1

1 reference

17 November 2017

Gerald Levy

series ordinal

2

1 reference

17 November 2017

Fang Niu

series ordinal

3

1 reference

17 November 2017

Felicia Bixler

series ordinal

4

1 reference

17 November 2017

language of work or name

English

0 references

publication date

6 October 2009

1 reference

Annals of Pharmacotherapy

17 November 2017

published in

1 reference

17 November 2017

volume

43

1 reference

17 November 2017

issue

11

1 reference

17 November 2017

page(s)

1765-1773

1 reference

Systematic overview of warfarin and its drug and food interactions

17 November 2017

cites work

1 reference

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

21 January 2018

1 reference

Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment

21 January 2018

1 reference

Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance

21 January 2018

1 reference

Concomitant coumarin-NSAID therapy and risk for bleeding

21 January 2018

1 reference

Assessment of potential drug-drug interactions with a prescription claims database

21 January 2018

1 reference

Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

21 January 2018

1 reference

Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials

21 January 2018

1 reference

A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury

21 January 2018

1 reference

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

21 January 2018

1 reference

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

21 January 2018

1 reference

Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial.

21 January 2018

1 reference

Possible international normalized ratio elevation associated with celecoxib and warfarin in an elderly psychiatric patient

21 January 2018

1 reference

Warfarin and celecoxib interaction.

21 January 2018

1 reference

Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication.

21 January 2018

1 reference

Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors

21 January 2018

1 reference

Bleeding complications in patients on celecoxib and warfarin

21 January 2018

1 reference

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

Rare outcomes, common treatments: analytic strategies using propensity scores.

21 January 2018

1 reference

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M284

1 reference

17 November 2017

1 reference